Search Results - "Ma, Sung Jun"

Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapy by Ma, Sung Jun, Serra, Lucas M., Yu, Brian, Bartl, Austin J., Farrugia, Mark K., Oladeru, Oluwadamilola T., Singh, Anurag K.

“…Purpose To evaluate the association of various gene expression assays with pathologic complete response (pCR) in the setting of neoadjuvant chemotherapy among…”
Get full text

Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer by Gill, Jasmin, Yendamuri, Keerti, Chatterjee, Udit, Yao, Song, Oladeru, Oluwadamilola T, Singh, Anurag K, Ma, Sung Jun

“…Despite numerous studies on racial/ethnic disparities among patients with breast cancer, there is a paucity of literature evaluating racial/ethnic differences…”
Get full text

Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer by Ma, Sung Jun, Gill, Jasmin, Yendamuri, Keerti, Chatterjee, Udit, Waldman, Olivia, Dunne-Jaffe, Cynthia, Fekrmandi, Fatemeh, Shekher, Rohil, Iovoli, Austin, Yao, Song, Oladeru, Oluwadamilola T, Singh, Anurag K

“…Progesterone receptor (PR)-negative tumors have been shown to have worse prognosis and were underrepresented in recent trials on patients with estrogen…”
Get full text

Radiation Therapy for Patients with Advanced Renal Cell Carcinoma by Miccio, Joseph A., Oladeru, Oluwadamilola T., Jun Ma, Sung, Johung, Kimberly L.

“…Stereotactic radiosurgery and stereotactic body radiation therapy (SBRT) have led to a resurgence of the use of radiotherapy in the management of advanced…”
Get full text

Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study by Virk, Jas, Gill, Jasmin, Fekrmandi, Fatemeh, Iovoli, Austin, Farrugia, Mark, Al-Afif, Ayham, Wooten, Kimberly, Gupta, Vishal, McSpadden, Ryan, Kuriakose, Moni A, Markiewicz, Michael R, Hicks, Jr, Wesley L, Ma, Sung Jun, Singh, Anurag K

“…The National Comprehensive Cancer Network (NCCN) guideline recommends consideration of weekly cisplatin as an alternative option for patients with head and…”
Get full text

Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation by Yu, Brian, Ma, Sung Jun, Khan, Michael, Gill, Jasmin, Iovoli, Austin, Fekrmandi, Fatemeh, Farrugia, Mark K, Wooten, Kimberly, Gupta, Vishal, McSpadden, Ryan, Kuriakose, Moni A, Markiewicz, Michael R, Al-Afif, Ayham, Hicks, Jr, Wesley L, Seshadri, Mukund, Ray, Andrew D, Repasky, Elizabeth A, Singh, Anurag K

“…Given the role of systematic inflammation in cancer progression, lymphocyte-monocyte ratio (LMR) from peripheral blood has been suggested as a biomarker to…”
Get full text

Vertebral body collapse after spine stereotactic body radiation therapy: a single-center institutional experience by Issany, Arsh, Iovoli, Austin J, Wang, Richard, Shekher, Rohil, Ma, Sung Jun, Goulenko, Victor, Fekrmandi, Fatemeh, Prasad, Dheerendra

“…Spine stereotactic body radiation therapy (SBRT) for the treatment of metastatic disease is increasingly utilized owing to improved pain and local control over…”
Get full text

Effect of musculature on mortality, a retrospective cohort study by Shaver, Amy L, Platek, Mary E, Singh, Anurag K, Ma, Sung Jun, Farrugia, Mark, Wilding, Gregory, Ray, Andrew D, Ochs-Balcom, Heather M, Noyes, Katia

“…While often life-saving, treatment for head and neck cancer (HNC) can be debilitating resulting in unplanned hospitalization. Hospitalizations in cancer…”
Get full text

Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy by Huang, Karen, Prasad, Sharan, Ma, Sung Jun, Yu, Han, Iovoli, Austin J, Farrugia, Mark K, Dexter, Elizabeth U, Demmy, Todd L, Malik, Nadia K, Singh, Anurag K

“…The role of neutrophil-lymphocyte ratio (NLR) as a predictor for survival in single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains…”
Get full text

Long-term outcomes of interventions for radiation-induced xerostomia: A review by Ma, Sung Jun, Rivers, Charlotte I, Serra, Lucas M, Singh, Anurag K

“…Xerostomia, or dry mouth, is a significant problem affecting quality of life in patients treated with radiation therapy for head and neck cancer. Strategies…”
Get full text

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer by Ma, Sung Jun, Prezzano, Kavitha M, Hermann, Gregory M, Singh, Anurag K

“…Dose escalation of conventionally fractionated radiation therapy (CFRT) above 45-54 Gy has an unclear survival benefit. Prior National Cancer Database (NCDB)…”
Get full text

Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non–Small Cell Lung Cancer by Yu, Brian, Jun Ma, Sung, Waldman, Olivia, Dunne-Jaffe, Cynthia, Chatterjee, Udit, Turecki, Lauren, Gill, Jasmin, Yendamuri, Keerti, Iovoli, Austin, Farrugia, Mark, Singh, Anurag K.

“…ImportanceNational guidelines allow consideration of postoperative radiation therapy (PORT) among patients with incompletely resected non–small cell lung…”
Get full text

An epigenome-wide analysis of socioeconomic position and tumor DNA methylation in breast cancer patients by Chen, Jianhong, Long, Mark D, Sribenja, Sirinapa, Ma, Sung Jun, Yan, Li, Hu, Qiang, Liu, Song, Khoury, Thaer, Hong, Chi-Chen, Bandera, Elisa, Singh, Anurag K, Repasky, Elizabeth A, Bouchard, Elizabeth G, Higgins, Michael, Ambrosone, Christine B, Yao, Song

“…Disadvantaged socioeconomic position (SEP), including lower educational attainment and household income, may influence cancer risk and outcomes. We…”
Get full text

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer by Singh, Anurag K, Hennon, Mark, Ma, Sung Jun, Demmy, Todd L, Picone, Anthony, Dexter, Elizabeth U, Nwogu, Chumy, Attwood, Kristopher, Tan, Wei, Hermann, Gregory M, Fung-Kee-Fung, Simon, Malhotra, Harish K, Yendamuri, Sai, Gomez-Suescun, Jorge A

“…Standard therapy for stage III non-small cell lung cancer with chemotherapy and conventional radiation has suboptimal outcomes. We hypothesized that a…”
Get full text

Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC by Iovoli, Austin J, Prasad, Sharan, Ma, Sung Jun, Fekrmandi, Fatemeh, Malik, Nadia K, Fung-Kee-Fung, Simon, Farrugia, Mark K, Singh, Anurag K

“…This study aims to report our 13-year institutional experience with single-fraction stereotactic body radiation therapy (SF-SBRT) for early stage NSCLC. A…”
Get full text

Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancer by Han, Hye Ri, Ma, Sung Jun, Hermann, Gregory M, Iovoli, Austin J, Wooten, Kimberly E, Arshad, Hassan, Gupta, Vishal, McSpadden, Ryan P, Kuriakose, Moni A, Markiewicz, Michael R, Chan, Jon M, Platek, Mary E, Ray, Andrew D, Gu, Fangyi, Hicks, Jr, Wesley L, Singh, Anurag K

“…To compare head and neck cancer (HNC) patients treated with three-weekly versus weekly cisplatin-based or other chemotherapy-based concurrent chemoradiation…”
Get full text

Association of low adherence to weekly cisplatin with outcomes in patients with head and neck cancer treated with chemoradiation by Virk, Jas, Gill, Jasmin, Fekrmandi, Fatemeh, Iovoli, Austin, Farrugia, Mark, Ma, Sung Jun, Singh, Anurag K.

“…e18053 Background: The National Comprehensive Cancer Network (NCCN) guideline recommends consideration of weekly cisplatin as an alternative option for…”
Get full text

Association of absolute neutrophil count with outcomes in patients with head and neck cancer treated with chemoradiation by Gill, Jasmin, Virk, Jas, Fekrmandi, Fatemeh, Iovoli, Austin, Farrugia, Mark, Ma, Sung Jun, Singh, Anurag K.

“…e18055 Background: Systematic inflammation plays an integral role in tumor development and metastasis. High neutrophil counts, among various peripheral blood…”
Get full text

Association of human epidermal growth factor receptor 2 expression with 21-gene recurrence score and survival among patients with estrogen receptor–positive breast cancer by Ma, Sung Jun, Gill, Jasmin, Yendamuri, Keerti, Yao, Song, Oladeru, Oluwadamilola Temilade, Singh, Anurag K.

“…563 Background: Trastuzumab-deruxtecan was recently shown to improve survival for metastatic human epidermal growth factor receptor 2 (HER2)-low breast cancer…”
Get full text

Omission of adjuvant chemotherapy in elderly patients with early stage breast cancer by Ma, Sung Jun, Oladeru, Oluwadamilola Temilade, Singh, Anurag K

“…Abstract only 12032 Background: Breast cancer incidence in elderly population over 70 years is anticipated to grow up to 35% by 2030. However, this elderly…”
Get full text